[1]
“Evaluation of the Antibacterial Potential of Cephalexin Schiff Bases against Bacillus Pumilus and Candida albicans”, Acad. Sci. J., vol. 1, no. 4, pp. 384–396, Oct. 2023, doi: 10.24237/ASJ.01.04.765I.